Handelsbanken Fonder’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-63,300
Closed -$20.6M 1602
2024
Q1
$20.6M Buy
63,300
+56,200
+792% +$13.8M 0.09% 216
2023
Q4
$1.35M Buy
7,100
+700
+11% +$132K 0.01% 685
2023
Q3
$1.27M Hold
6,400
0.01% 651
2023
Q2
$1.83M Sell
6,400
-300
-4% -$83.3K 0.01% 564
2023
Q1
$1.45M Buy
6,700
+1,400
+26% +$273K 0.01% 591
2022
Q4
$1.09M Buy
5,300
+400
+8% +$101K 0.01% 629
2022
Q3
$1.36M Sell
4,900
-900
-16% -$229K 0.01% 580
2022
Q2
$1.11M Buy
5,800
+800
+16% +$141K 0.01% 648
2022
Q1
$1.04M Sell
5,000
-1,500
-23% -$247K 0.01% 780
2021
Q4
$1.16M Sell
6,500
-1,500
-19% -$296K 0.01% 822
2021
Q3
$1.65M Buy
8,000
+700
+10% +$137K 0.01% 683
2021
Q2
$1.39M Buy
7,300
+1,400
+24% +$229K 0.01% 757
2021
Q1
$769K Sell
5,900
-100
-2% -$12K ﹤0.01% 972
2020
Q4
$622K Buy
6,000
+2,400
+67% +$208K ﹤0.01% 1039
2020
Q3
$273K Buy
+3,600
New +$204K ﹤0.01% 1286

Other funds holding SWAV

Handelsbanken Fonder's SWAV Position: Q2 2024 in Review

Handelsbanken Fonder sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 63,300 shares — an estimated $20.6M sold.

Handelsbanken Fonder first reported a position in SWAV in Q3 2020 and held it in 15 quarters. The position peaked at $20.6M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Handelsbanken Fonder reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Handelsbanken Fonder sold 63,300 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $20.6M.
  • Handelsbanken Fonder first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
  • Handelsbanken Fonder's Shockwave Medical, Inc. Common Stock position peaked at $20.6M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.